小费
发表于 2025-3-21 19:22:15
书目名称Intellectual Property Rights in Pharmaceutical Test Data影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0469217<br><br> <br><br>书目名称Intellectual Property Rights in Pharmaceutical Test Data读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0469217<br><br> <br><br>
catagen
发表于 2025-3-21 20:24:16
http://reply.papertrans.cn/47/4693/469217/469217_2.png
olfction
发表于 2025-3-22 03:36:28
http://reply.papertrans.cn/47/4693/469217/469217_3.png
漂亮才会豪华
发表于 2025-3-22 07:22:02
http://reply.papertrans.cn/47/4693/469217/469217_4.png
共同确定为确
发表于 2025-3-22 11:46:43
Conclusion,This final chapter first summarises the major findings of this book before moving to discuss some of the implications of those findings. Finally, it offers a few concluding remarks on the book as a whole.
彩色
发表于 2025-3-22 16:09:50
http://reply.papertrans.cn/47/4693/469217/469217_6.png
Admonish
发表于 2025-3-22 19:57:32
An Overview of the Protection of Submitted Test Data, this book. Firstly, the role of pharmaceutical test data in the process of drug development is described. Secondly, this chapter provides an overview of the issues surrounding the protection of submitted pharmaceutical test data, and in particular the issues surrounding test data exclusivity. Both
Dawdle
发表于 2025-3-22 22:32:25
http://reply.papertrans.cn/47/4693/469217/469217_8.png
LAITY
发表于 2025-3-23 04:25:12
http://reply.papertrans.cn/47/4693/469217/469217_9.png
旧石器时代
发表于 2025-3-23 06:42:12
The Globalisation of Test Data Exclusivity,lusivity requirements in trade agreements and other instruments have evolved over time and between parties. The chapter firstly examines the role that trade agreements negotiated by the US, EFTA/Switzerland and EU have played in the globalisation of test data exclusivity. Then, the chapter moves to